Demonstrates accurate glucose prediction in insulin-dependent T1DM patients, suggesting advancements in metabolic health management.
values of 0.9397 and 0.8549. This framework offers a practical, data-driven strategy for short-term glucose forecasting and metabolic health management in insulin-dependent T1DM patients, while the quantitative validation of its non-invasiveness provides a robust basis for wearable sensor-based glucose monitoring.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: